SBF
OGEN icon

Sara-Bay Financial’s Oragenics OGEN Stock Holding History

Sara-Bay Financial’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-706
Closed -$134K – 84
2022
Q4 		$134K Sell
706
-410
-37% -$145K 0.08% 76
2022
Q3 		$456K Hold
1,116
– – 0.25% 44
2022
Q2 		$6.92M Hold
1,116
– – 3.36% 8
2022
Q1 		$692K Hold
1,116
– – 0.27% 36
2021
Q4 		$896K Buy
1,116
+556
+99% +$563K 0.27% 31
2021
Q3 		$640K Hold
560
– – 0.25% 37
2021
Q2 		$713K Hold
560
– – 0.27% 33
2021
Q1 		$914K Hold
560
– – 0.37% 25
2020
Q4 		$453K Sell
560
-172
-23% -$151K 0.2% 45
2020
Q3 		$758K Sell
732
-2
-0.3% -$3.2K 0.41% 24
2020
Q2 		$1.07M Buy
+734
New +$722K 0.61% 21

Other funds holding OGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

Sara-Bay Financial's OGEN Position: Q1 2023 in Review

Sara-Bay Financial sold out of Oragenics (OGEN) in Q1 2023, closing a stake of 706 shares — an estimated $134K sold.

Sara-Bay Financial first reported a position in OGEN in Q2 2020 and held it in 11 quarters. The position peaked at $6.92M in Q2 2022. 10 funds tracked by Wall St. Rank hold OGEN as of Q1 2023.

  • Sara-Bay Financial reported no remaining Oragenics position as of Q1 2023 after selling out during the quarter.
  • Sara-Bay Financial sold 706 Oragenics shares in Q1 2023, an estimated $134K.
  • Sara-Bay Financial first reported a position in Oragenics in Q2 2020 and held it in 11 quarters.
  • Sara-Bay Financial's Oragenics position peaked at $6.92M in Q2 2022.
  • 10 funds tracked by Wall St. Rank held Oragenics as of Q1 2023.

Based on Sara-Bay Financial's 13F filing for Q1 2023, filed 14 Apr 2023.